Literature DB >> 1790638

Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study.

G D Sebastiani1, G Passiu, M Galeazzi, F Porzio, U Carcassi.   

Abstract

The main objectives of the present study were to determine the prevalence of IgG and IgM anticardiolipin antibody (aCL) isotypes in systemic lupus erythematosus (SLE) in order to analyze their possible association with the clinical manifestations of the disease. Clinical features of 64 consecutive and unselected SLE patients were prospectively studied. Sera from the same patients taken during each clinical manifestation were tested for the presence of aCL. The prevalence of aCL was 43.75% for the IgG isotype and 9.4% for the IgM isotype. A strong linkage between the presence of these antibodies and the occurrence of both thrombosis and abortions was found: a weaker association with neurological events and thrombocytopenia was also demonstrated. The titre of aCL appeared to be linked with the probability of having the clinical manifestations associated with these autoantibodies. Our results suggest that thrombosis and abortion, and possibly thrombocytopenia and central nervous system involvement, may be associated with the presence of aCL at the time when these clinical events develop in SLE patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1790638     DOI: 10.1007/bf02208692

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

Review 1.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

2.  Lupus anticoagulant, thrombosis, and fetal loss.

Authors:  D I Feinstein
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

3.  Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

Authors:  M A Khamashta; E N Harris; A E Gharavi; G Derue; A Gil; J J Vázquez; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

Review 4.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

5.  Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.

Authors:  R A Asherson; D Mercey; G Phillips; N Sheehan; A E Gharavi; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

6.  Anticardiolipin antibodies in patients with systemic lupus erythematosus.

Authors:  G Sturfelt; O Nived; R Norberg; R Thorstensson; K Krook
Journal:  Arthritis Rheum       Date:  1987-04

7.  Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody.

Authors:  E N Harris; R A Asherson; A E Gharavi; S H Morgan; G Derue; G R Hughes
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

8.  Anticardiolipin antibodies in patients with rheumatic diseases.

Authors:  J G Fort; F S Cowchock; J L Abruzzo; J B Smith
Journal:  Arthritis Rheum       Date:  1987-07

9.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

10.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08
View more
  6 in total

Review 1.  Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.

Authors:  I Uthman; M Khamashta
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

2.  Antı-β2 Glycoprotein I Antibodies in Children with Rheumatologic Disorders.

Authors:  Elif Azarsiz; Gamze Eman; Sanem Eren Akarcan; Ezgi Ulusoy Severcan; Neslihan Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Indian J Clin Biochem       Date:  2017-11-10

3.  Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis.

Authors:  A Afeltra; M Galeazzi; G M Ferri; A Amoroso; O De Pità; F Porzio; L Bonomo
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

4.  Abnormalities of magnetic resonance imaging of the central nervous system in patients with systemic lupus erythematosus correlate with disease severity.

Authors:  A Cauli; C Montaldo; M T Peltz; P Nurchis; G Sanna; P Garau; R Pala; G Passiu; A Mathieu
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

Review 5.  The antiphospholipid syndrome: from pathophysiology to treatment.

Authors:  Simone Negrini; Fabrizio Pappalardo; Giuseppe Murdaca; Francesco Indiveri; Francesco Puppo
Journal:  Clin Exp Med       Date:  2016-06-22       Impact factor: 3.984

Review 6.  Antiphospholipid Antibodies in Inflammatory and Autoimmune Rheumatic and Musculoskeletal Diseases Beyond Lupus: A Systematic Review of the Available Evidence.

Authors:  Georges El Hasbani; Mario Viola; Savino Sciascia; Ali T Taher; Imad Uthman
Journal:  Rheumatol Ther       Date:  2021-01-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.